Immune System ‘Atlas’ Will Speed Detection Of Kidney Transplant Rejection, Stanford/Packard Researchers Say

February 24, 2009 at 2:00 pm Leave a comment


Scientists at the Stanford University School of Medicine and Lucile Packard Children’s Hospital have devised a new way to decode the immune signals that cause slow, chronic rejection of all transplanted kidneys. They’ve created an immune-system “atlas” that will improve doctors’ ability to monitor transplanted organs and shed light on the mechanisms of gradual, cumulative kidney malfunction after transplant.




“The reason chronic injury occurs in transplanted organs is really a mystery,” said senior study author Minnie Sarwal, MD, PhD, professor of pediatrics at the School of Medicine and a nephrologist at Packard Children’s Hospital. “Even patients who receive an organ from an identical twin develop chronic rejection.”




The findings will be published online Feb. 23 in the Proceedings of the National Academy of Sciences.




Before an organ transplant, doctors check for compatibility between the donor’s and recipient’s immune systems, Sarwal said. They examine the genes encoding small proteins, called human leukocyte antigens, that label the exterior of every cell. These proteins are the immune system’s main mechanism for distinguishing “self” from “non-self” tissues. Only identical twins have perfectly matched human leukocyte antigens; for other organ recipients, doctors use a donor with the closest match they can find. After transplant, an organ recipient receives strong drugs that reduce the body’s ability to crank out antibodies – immune “search-and-destroy” markers – against the donated kidney.




But the fact that chronic organ rejection occurs even between twins suggests the immune system is doing more than keeping tabs on human leukocyte antigens.




The Stanford team set out to find what that was. The researchers devised a first-of-its-kind method to catalog every one of the antibodies attacking donated kidneys after transplant. They tracked evidence of all types of immune system attack by comprehensively comparing antibody levels in 18 kidney recipients before and after transplant. To do this, they melded two biological sleuthing systems, first comparing all proteins in the subjects’ blood to an array of more than 5,000 human proteins, then running the results from that analysis through a genetic database that showed which blood proteins were antibodies designed to attack the donated kidney.




“This is pretty revolutionary,” Sarwal said. “It opens the door to a lot of exciting work to personalize how we monitor these patients.” The new findings will allow inexpensive, noninvasive blood tests that show whether a donated kidney is infected, undergoing acute rejection or accruing chronic injuries that could cause long-term malfunction, she said.




“An individual’s antibody profile is a new aspect of human physiology that can now be surveyed in an unbiased way, the same way genes can,” said co-senior author Atul Butte, MD, PhD, assistant professor of medical informatics and of pediatrics. “That’s very exciting.” Butte is also a member of the Stanford Cancer Center. Unlike genes, the body’s antibodies change over time, a factor that could improve the effectiveness of personalized medicine, Butte said.




The team’s raw data on antibody profiles is now publicly available to other scientists through the Gene Expression Omnibus database maintained by the National Center for Biotechnology Information, a division of the National Library of Medicine.




In addition to improving patient monitoring, the team’s comprehensive list of anti-kidney antibodies will spur research on the mechanisms of chronic kidney rejection. For example, the study establishes for the first time what part of the kidney causes the largest immune response after transplant.




“To our great surprise, the most immunogenic region of the kidney is the renal pelvis,” Sarwal said. The renal pelvis is the cavity deep inside the organ that collects urine and funnels it toward the bladder. The next-largest immune responses were observed at the cortex and glomerulus, regions of the kidney with large blood supplies and extensive exposure to the recipient’s immune system. The next step in understanding chronic organ rejection will be to identify which specific anti-kidney antibodies are the most reliable harbingers of renal malfunction, Sarwal said.




“If we can correlate these antibodies with clinical events in the organ, we’ll have the tools to extend the life of kidney transplants,” Sarwal concluded.




Other Stanford co-authors include Li Li, senior biostatistician in pediatric nephrology; Persis Wadia, PhD, postdoctoral scholar; Rong Chen, PhD, research software engineer; Neeraja Kambham, MD, associate professor of pathology; Maarten Naesens, PhD, visiting research scholar in pediatric nephrology; Tara Sigdel, PhD, postdoctoral scholar in pediatrics; and David Miklos, MD, PhD, assistant professor of blood and marrow transplantation and a member of the Stanford Cancer Center. The research was funded by grants from the National Institute of Allergy and Infectious Disease and the National Library of Medicine.



Stanford University Medical Center integrates research, medical education and patient care at its three institutions – Stanford University School of Medicine, Stanford Hospital & Clinics and Lucile Packard Children’s Hospital at Stanford. For more information, please visit the Web site of the medical center’s Office of Communication & Public Affairs at http://mednews.stanford.edu.




Ranked as one of the best pediatric hospitals in the nation by U.S.News & World Report, Lucile Packard Children’s Hospital at Stanford is a 272-bed hospital devoted to the care of children and expectant mothers. Providing pediatric and obstetric medical and surgical services and associated with the Stanford University School of Medicine, Packard Children’s offers patients locally, regionally and nationally the full range of health-care programs and services – from preventive and routine care to the diagnosis and treatment of serious illness and injury.



Lucile Packard Children’s Hospital

[Via http://www.medicalnewstoday.com]

Advertisements

Entry filed under: Uncategorized.

The Children’s Hospital Of Philadelphia Recognized As A ‘Fertile Hope Center Of Excellence’ Cardiovascular Disease Treatment Guidelines Frequently Not Based On Solid Evidence

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Trackback this post  |  Subscribe to the comments via RSS Feed


Archives

Top Clicks

  • None

Blog Stats

  • 15,525 hits

%d bloggers like this: